Syncom Formulations posts 139% profit surge in Q4 FY25

Mumbai, June 4: Syncom Formulations (India) Ltd reported a 139% rise in net profit for the fourth quarter of FY25, with profit after tax reaching Rs 1,769 lakh, up from Rs 740 lakh a year earlier. Quarterly revenue doubled to Rs 14,888 lakh, while EBITDA rose 97% to Rs 2,469 lakh.

For the full fiscal year, revenue climbed 76% to Rs 46,501 lakh, and annual net profit nearly doubled to Rs 4,943 lakh. The company attributed the strong performance to growing demand, operational efficiency, and expansion in both domestic and global markets.

With operations in 25 countries and over 400 registered products, Syncom plans to deepen its presence in India through a strong marketing network and focused healthcare divisions.